Quote:
Originally Posted by roadaction13
Do they consider previous use of short-term SoluMedrol to be immunosuppressive?
|
"In addition, patients treated with an immunosuppressant (IS) prior to receiving TYSABRI have an increased risk of PML;
IS use includes agents such as mitoxantrone, azathioprine, methotrexate, cyclophosphamide, mycophenolate and
cladribine, rituximab, and chemotherapy (not otherwise specified)."
Short term SoluMedrol not listed as IS